Just Articles
#1 in Business Subscribe Email Print

You are here: Home > Business > Management > How To Bring Database Management In Tune With Regulatory Compliance

Tags

  • access
  • pharmaceutical
  • systems
  • unauthorized access
  • unauthorized access
  • developing combination

  • Links

  • Cleanup and Migration of Access Database to Microsoft SQL Server - Part 2
  • Writing Is Hard Work but Don't Be Discouraged
  • Send Gift Flowers
  • Just Articles - How To Bring Database Management In Tune With Regulatory Compliance

    New regulations regarding financial controls and statements have necessitated an overhauling of collection, retention and management procedures as far as in
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    formation is concerned.

    What is Regulatory Compliance? Regulatory Compliance Acts make it mandatory for public companies to evaluate, review, restructure
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    and make a detailed report of the internal controls in place for financial statements. The report has to be given a “clean chit” by external auditors. These
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    Acts seek to prevent financial misstatements, and reduce fraud in public companies.

    Data Management: IT is an important tool when it comes to data manage
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    ment to ensure regulatory compliance. IT tools are used for accessing and maintaining records, and protecting the financial systems from misuse. Here are so
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    me tips to ensure good data management practices.

    1) The appropriate management must be notified of data management ownership and they must understand thei
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    r responsibilities.

    2) Data systems should be listed, their managers notified, and the number of databases, types of information software used, the underly
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    ing operating system, access conditions, and other utilities should be listed.

    3) Review the potential threats to information stored in databases, and call
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    for periodic reassessments.

    4) The data should be properly catalogued, so extraction and tracking become easier.

    5) There should be data backup in place.
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ


    6) The responsibilities regarding database management must be delegated in a way that it prevents unauthorized access to information, as well as alteratio
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    ns to the data.

    Database Management: Database Administrators. In order to ensure regulatory compliance, database management is broken up into different t
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    asks and each task is delegated to a database administrator, or DBA. The DBA’s responsibilities include:

    1) Being accountable for the integrity of the data
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    .
    2) Authorizing and tracking database modifications and management of security of the system.
    3) Ensuring proper backup for database.
    4) E
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    nsuring that the database is foolproof against unauthorized access.
    5) Maintain a list of all databases, and databases other than their own that they a
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    ccess information from.
    6) Keep proper documents in place establishing that they follow legal practices regarding access and privileges.
    7) Test
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    database log validation procedures.
    8) Rectify the database quickly when unauthorized access and changes to the database are noticed.
    9) Ensure t
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    hat in case of an accidental or premeditated loss of data, it can be recovered in the minimum possible time so that business is not affected.


    Database
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    management procedures should satisfy auditors, be legal, and should employ correct auditing methods. There are companies that provide these services. Howev
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    er, they should be aware of their duties and responsibilities and ensure regulatory compliance of their database management processes. Upgrading the databas
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    e system and putting in proper controls to information access and flow keeps the organization in the good books of auditors, and prevents financial scandals


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.justarticles.org.ua/article/21438/justarticles-How-To-Bring-Database-Management-In-Tune-With-Regulatory-Compliance.html">How To Bring Database Management In Tune With Regulatory Compliance</a>

    BB link (for phorums):
    [url=http://www.justarticles.org.ua/article/21438/justarticles-How-To-Bring-Database-Management-In-Tune-With-Regulatory-Compliance.html]How To Bring Database Management In Tune With Regulatory Compliance[/url]

    Related Articles:

    Commercial Debt Management - Commercial Debt Management Is A Strong Business Tool

    Preparing For A Job Interview: Techniques You May Not Have Thought Of

    Who Wants To Be An Entrepreneur Anyway?

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com